TY - JOUR
T1 - Pain management after laminectomy
T2 - a systematic review and procedure-specific post-operative pain management (prospect) recommendations
AU - PROSPECT Working Group Collaborators
AU - European Society of Regional Anaesthesia
AU - Peene, Laurens
AU - Le Cacheux, Pauline
AU - Sauter, Axel R.
AU - Joshi, Girish P.
AU - Beloeil, Helene
AU - Joshi, G. P.
AU - Pogatzki-Zahn, E.
AU - Van de Velde, M.
AU - Schug, S.
AU - Kehlet, H.
AU - Bonnet, F.
AU - Rawal, N.
AU - Delbos, A.
AU - Lavand’homme, P.
AU - Raeder, J.
AU - Albrecht, E.
AU - Lirk, P.
AU - Freys, S.
AU - Lobo, D.
N1 - Funding Information:
PROSPECT is supported by an unrestricted grant from the European Society of Regional Anaesthesia and Pain Therapy (ESRA). In the past, PROSPECT had received unrestricted grants from Pfizer Inc. New York, NY, USA, and Grunenthal, Aachen, Germany.
Publisher Copyright:
© 2020, The Author(s).
PY - 2021/10
Y1 - 2021/10
N2 - Purpose: With lumbar laminectomy increasingly being performed on an outpatient basis, optimal pain management is critical to avoid post-operative delay in discharge and readmission. The aim of this review was to evaluate the available literature and develop recommendations for optimal pain management after one- or two-level lumbar laminectomy. Methods: A systematic review utilizing the PROcedure-SPECific Post-operative Pain ManagemenT (PROSPECT) methodology was undertaken. Randomised controlled trials (RCTs) published in the English language from 1 January 2008 until 31 March 2020—assessing post-operative pain using analgesic, anaesthetic and surgical interventions—were identified from MEDLINE, EMBASE and Cochrane Databases. Results: Out of 65 eligible studies identified, 39 RCTs met the inclusion criteria. The analgesic regimen for lumbar laminectomy should include paracetamol and a non-steroidal anti-inflammatory drug (NSAID) or cyclooxygenase (COX)—2 selective inhibitor administered preoperatively or intraoperatively and continued post-operatively, with post-operative opioids for rescue analgesia. In addition, surgical wound instillation or infiltration with local anaesthetics prior to wound closure is recommended. Some interventions—gabapentinoids and intrathecal opioid administration—although effective, carry significant risks and consequently were omitted from the recommendations. Other interventions were also not recommended because there was insufficient, inconsistent or lack of evidence. Conclusion: Perioperative pain management for lumbar laminectomy should include paracetamol and NSAID- or COX-2-specific inhibitor, continued into the post-operative period, as well as intraoperative surgical wound instillation or infiltration. Opioids should be used as rescue medication post-operatively. Future studies are necessary to evaluate the efficacy of our recommendations.
AB - Purpose: With lumbar laminectomy increasingly being performed on an outpatient basis, optimal pain management is critical to avoid post-operative delay in discharge and readmission. The aim of this review was to evaluate the available literature and develop recommendations for optimal pain management after one- or two-level lumbar laminectomy. Methods: A systematic review utilizing the PROcedure-SPECific Post-operative Pain ManagemenT (PROSPECT) methodology was undertaken. Randomised controlled trials (RCTs) published in the English language from 1 January 2008 until 31 March 2020—assessing post-operative pain using analgesic, anaesthetic and surgical interventions—were identified from MEDLINE, EMBASE and Cochrane Databases. Results: Out of 65 eligible studies identified, 39 RCTs met the inclusion criteria. The analgesic regimen for lumbar laminectomy should include paracetamol and a non-steroidal anti-inflammatory drug (NSAID) or cyclooxygenase (COX)—2 selective inhibitor administered preoperatively or intraoperatively and continued post-operatively, with post-operative opioids for rescue analgesia. In addition, surgical wound instillation or infiltration with local anaesthetics prior to wound closure is recommended. Some interventions—gabapentinoids and intrathecal opioid administration—although effective, carry significant risks and consequently were omitted from the recommendations. Other interventions were also not recommended because there was insufficient, inconsistent or lack of evidence. Conclusion: Perioperative pain management for lumbar laminectomy should include paracetamol and NSAID- or COX-2-specific inhibitor, continued into the post-operative period, as well as intraoperative surgical wound instillation or infiltration. Opioids should be used as rescue medication post-operatively. Future studies are necessary to evaluate the efficacy of our recommendations.
KW - Analgesia
KW - Evidence-based medicine
KW - Laminectomy
KW - Systematic review
UR - http://www.scopus.com/inward/record.url?scp=85097259462&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097259462&partnerID=8YFLogxK
U2 - 10.1007/s00586-020-06661-8
DO - 10.1007/s00586-020-06661-8
M3 - Review article
C2 - 33247353
AN - SCOPUS:85097259462
SN - 0940-6719
VL - 30
SP - 2925
EP - 2935
JO - European Spine Journal
JF - European Spine Journal
IS - 10
ER -